- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Caplin Point Laboratories Ltd (CAPL)
Track today's live Caplin Point Laboratories Ltd (CAPL) share price, performance and key data on this page with our current NSE:CAPL stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Caplin Point Laboratories Ltd share price on the NSE exchange. Use the dropdown to switch exchange for the CAPL share price, head to our technical summary section, which provides analysis on Caplin Point Laboratories Ltd share price buy/sell indicators using real-time data (or discuss the Caplin Point Laboratories Ltd (CAPL) stock price today with other investors in the Caplin Point Laboratories Ltd NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:CAPL share price (ISIN: INE475E01026) to enhance your trading decisions with our free investment tools and resources.
What Is the Caplin Point Laboratories Ltd Share Price Today?
The Caplin Point Laboratories Ltd share price today is 2,480.50.
What Is the Stock Symbol for Caplin Point Laboratories Ltd
The stock symbol (or 'ticker') for Caplin Point Laboratories Ltd is "CAPL."
What Stock Exchange Does Caplin Point Laboratories Ltd Trade On?
Caplin Point Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Caplin Point Laboratories Ltd a Good Stock to Buy?
Determining whether Caplin Point Laboratories Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:CAPL share price (ISIN: INE475E01026) to enhance your trading decisions with our free investment tools and resources.
What Is the Caplin Point Laboratories Ltd Share Price Today?
The Caplin Point Laboratories Ltd share price today is 2,480.50.
What Is the Stock Symbol for Caplin Point Laboratories Ltd
The stock symbol (or 'ticker') for Caplin Point Laboratories Ltd is "CAPL."
What Stock Exchange Does Caplin Point Laboratories Ltd Trade On?
Caplin Point Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Caplin Point Laboratories Ltd a Good Stock to Buy?
Determining whether Caplin Point Laboratories Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
2,480.50
-19.20(-0.77%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,460.60
2,519.70
52 wk Range
1,500.30
2,699.00
CAPL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,460.602,519.70
52 wk Range
1,500.302,699.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CAPL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Caplin Point Laboratories Ltd Earnings Call Summary for Q1/2027
- Caplin Point reported 20% revenue growth in Q1 2026 with EBITDA margin rising to 38.4%; shares fell 6.3% to $2,464 despite strong results.
- U.S. subsidiary Caplin Steriles tripled revenue to INR 43.1 crores; gross margin held at 59.8%, above the 55% target with zero external debt.
- Management cited capacity, not demand, as main constraint; company booked until February 2026 with plants near full utilization.
- Plans to expand sterile injectable lines from 7 to 17; Line 7 expected in 6-7 months, five more within a year to address capacity bottleneck.
- Cash reserves surged to INR 1,500 crores from INR 231 crores; company targeting 60% gross margin with disciplined operating expense management.
Last Updated: 12/08/2026, 13:12
Read Full TranscriptEarnings
Latest Release
12/08/2026
EPS / Forecast
23.30 / --
Revenue / Forecast
6.1B / 5.21B
Compare CAPL to Peers and Sector
Metrics to compare | CAPL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCAPLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.3x | 32.8x | −0.4x | |
PEG Ratio | 1.58 | 0.59 | 0.00 | |
Price/Book | 5.4x | 3.7x | 2.6x | |
Price / LTM Sales | 8.2x | 3.8x | 3.1x | |
Upside (Analyst Target) | 1.0% | 3.8% | 47.8% | |
Fair Value Upside | Unlock | 2.1% | 6.2% | Unlock |
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Caplin Point Laboratories Ltd (NSE: CAPL) Share Price Today?
The Caplin Point Laboratories Ltd stock price today is 2,480.50 INR.
What Stock Exchange Does Caplin Point Laboratories Ltd (CAPL) Trade On?
Caplin Point Laboratories Ltd is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Caplin Point Laboratories Ltd?
The stock symbol (also called a 'ticker') for Caplin Point Laboratories Ltd is "CAPL."
Does Caplin Point Laboratories Ltd Pay Dividends? What’s The Current CAPL Dividend Yield?
Yes, CAPL Pays Dividends to its Shareholders. The current Caplin Point Laboratories Ltd dividend yield is 0.28%.
What Is the Current Caplin Point Laboratories Ltd Market Capitalisation?
As of today, Caplin Point Laboratories Ltd (NSE: CAPL) market cap is 188.55B INR.
What Is Caplin Point Laboratories Ltd's (CAPL) Earnings Per Share (TTM)?
The Caplin Point Laboratories Ltd EPS is currently 87.29 (Trailing Twelve Months).
When Is the Next Caplin Point Laboratories Ltd Earnings Date?
Caplin Point Laboratories Ltd's next earnings report will be released on 05/11/2026.
Is CAPL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Caplin Point Laboratories Ltd moving averages and other technical indicators, the daily buy/sell signal for CAPL stock is Strong Sell.
How Many Times Has Caplin Point Laboratories Ltd Stock Split?
Caplin Point Laboratories Ltd has split 1 times. (See the CAPL stock split history page for full effective split date and price information.)
How Many Employees Does Caplin Point Laboratories Ltd Have?
Caplin Point Laboratories Ltd has 3966 employees, based on their latest Companies House report.
What is the current trading status of Caplin Point Laboratories Ltd (NSE: CAPL)?
As of 15/08/2026, Caplin Point Laboratories Ltd (CAPL) is trading at a share price of 2,480.50 INR, with a previous close of 2,499.70 INR. The stock has fluctuated within a day range of 2,460.60 INR to 2,519.70 INR, while its 52-week range spans from 1,500.30 INR to 2,699.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.